#Biomanufacturing / Pharmaceutical Services #Industrial Biotech #Ag Tech & Green Tech #R&D Services and Products
- Directed evolution
- Continuous culture
- Adaptive laboratory evolution
- Strain development
- Natural selection
- Chemostat, turbidostat, etc.
As France's leading biocluster, Genopole is an incubator for cutting-edge projects in biotechnology. Located in the city of Évry, just south of Paris, Genopole provides a unique environment for scientists and entrepreneurs seeking to advance research and innovation.
Discover >Genopole accompanies researchers, postdocs and start-up entrepreneurs through all the phases of their projects to ensure the best possible conditions for business development.
Discover >Every day, at Genopole, researchers, entrepreneurs and students cross paths, share ideas and unite forces in a veritable melting pot for innovation.
Discover >Giving wings to research and empowering employment in our community are cornerstones of Genopole's mission. Catch up on recent scientific advances, the accomplishments of our biotech actors and the events that enliven the biocluster.
Discover >#Biomanufacturing / Pharmaceutical Services #Industrial Biotech #Ag Tech & Green Tech #R&D Services and Products
Altar is a specialist in the conception and operation of automated fluidic continuous culture systems for adaptive laboratory evolution and the development of microbial strains for industry.
BACKGROUND
Created in 2017, Alter is a biotech company specialized in automated microbial fluidics. The company runs a microorganism adaptive laboratory evolution platform at Genopole for research or propriety projects aimed at developing microorganisms of interest in industry.
DESCRIPTION OF THE PRODUCTS / SERVICES / TECHNOLOGY
Altar conceives and operates fluidic automated systems for the continuous culture of microbial suspensions. The company’s technology is used mainly in the setting of adaptive evolution experiments aimed at improving microorganism performance via natural selection. It enables the continuous culture of microbial suspensions under algorithm-controlled conditions for as long as is needed. Altar makes its technology and know-how available through collaborative projects or research services.
ACCOMPLISHMENTS / COLLABORATIONS / HIGHLIGHTS
Altar has benefited from an independent revenue stream since its creation thanks to the sale of research services to the food, chemistry, biofuels and health industries. The company also receives European subventions as a part of the H2020 eForFuel (www.eforfuel.eu) and SinFonia projects in partnership with public and private operatives. In 2020, Altar was chosen by the European Commission within the EIC Accelerator Pilot program’s Green Deal call for proposals.
COLLABORATIONS SOUGHT
To sustain its growth, Altar continuously seeks academic and industrial partners to deploy its technology for the development of microbial strains of interest
Number of employees: 9 employees and currently hiring
STRENGTHS
Team, technological leadership, market traction, current growth, independence and agility.
INNOVATION ASSETS
A visionary in in vivo adaptive laboratory evolution.
In same field